Since SFKi may affect PyVmT tyrosine phosphorylation (9), we treated the human luminal breast cancer cell line MCF7 and observed a similar effect on proliferation, as well as reduced FOXM1 expression, when SFKs were inhibited (Supplemental Figure 7B). The gene discussed is FOXM1; the disease is breast carcinoma.